mTORC1 signaling and regulation of pancreatic β-cell mass

References

• Um SH, Frigerio F, Watanabe M, Picard F, Joaquin M, Sticker M, et al. Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity. Nature 2004; 431:200 - 5; http://dx.doi.org/10.1038/nature02866; PMID: 15306821
   PubMed Web of Science ®Google Scholar
• Shah OJ, Wang Z, Hunter T. Inappropriate activation of the TSC/Rheb/mTOR/S6K cassette induces IRS1/2 depletion, insulin resistance, and cell survival deficiencies. Curr Biol 2004; 14:1650 - 6; http://dx.doi.org/10.1016/j.cub.2004.08.026; PMID: 15380067
   PubMed Web of Science ®Google Scholar
• Harrington LS, Findlay GM, Gray A, Tolkacheva T, Wigfield S, Rebholz H, et al. The TSC1-2 tumor suppressor controls insulin-PI3K signaling via regulation of IRS proteins. J Cell Biol 2004; 166:213 - 23; http://dx.doi.org/10.1083/jcb.200403069; PMID: 15249583
   PubMed Web of Science ®Google Scholar
• Khamzina L, Veilleux A, Bergeron S, Marette A. Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats: possible involvement in obesity-linked insulin resistance. Endocrinology 2005; 146:1473 - 81; http://dx.doi.org/10.1210/en.2004-0921; PMID: 15604215
   PubMed Web of Science ®Google Scholar
• Asahara S, Matsuda T, Kido Y, Kasuga M. Increased ribosomal biogenesis induces pancreatic beta cell failure in mice model of type 2 diabetes. Biochem Biophys Res Commun 2009; 381:367 - 71; http://dx.doi.org/10.1016/j.bbrc.2009.02.047; PMID: 19309774
   PubMed Web of Science ®Google Scholar
• Briaud I, Dickson LM, Lingohr MK, McCuaig JF, Lawrence JC, Rhodes CJ. Insulin receptor substrate-2 proteasomal degradation mediated by a mammalian target of rapamycin (mTOR)-induced negative feedback down-regulates protein kinase B-mediated signaling pathway in beta-cells. J Biol Chem 2005; 280:2282 - 93; http://dx.doi.org/10.1074/jbc.M412179200; PMID: 15537654
   PubMed Web of Science ®Google Scholar
• Rachdi L, Balcazar N, Osorio-Duque F, Elghazi L, Weiss AJ, Gould AP, et al. Disruption of Tsc2 in pancreatic beta cells induces beta cell mass expansion and improved glucose tolerance in a TORC1-dependent manner. Proc Natl Acad Sci USA 2008; 105:9250 - 5; http://dx.doi.org/10.1073/pnas.0803047105; PMID: 18587048
   PubMed Web of Science ®Google Scholar
• Shigeyama Y, Kobayashi T, Kido Y, Hashimoto N, Asahara S, Matsuda T, et al. Biphasic response of pancreatic beta-cell mass to ablation of tuberous sclerosis complex 2 in mice. Mol Cell Biol 2008; 28:2971 - 9; http://dx.doi.org/10.1128/MCB.01695-07; PMID: 18316403
   PubMed Web of Science ®Google Scholar
• Fraenkel M, Ketzinel-Gilad M, Ariav Y, Pappo O, Karaca M, Castel J, et al. mTOR inhibition by rapamycin prevents beta-cell adaptation to hyperglycemia and exacerbates the metabolic state in type 2 diabetes. Diabetes 2008; 57:945 - 57; http://dx.doi.org/10.2337/db07-0922; PMID: 18174523
   PubMed Web of Science ®Google Scholar
• Liu H, Remedi MS, Pappan KL, Kwon G, Rohatgi N, Marshall CA, et al. Both Glycogen Synthase Kinase-3 (GSK-3) and Mammalian Target of Rapamycin (mTOR) Pathways Contribute to DNA Synthesis, Cell Cycle Progression and Proliferation in Human Islets. Diabetes 2008; http://dx.doi.org/10.2337/db07-1208; PMID: 19073772
   PubMed Web of Science ®Google Scholar
• Murakami M, Ichisaka T, Maeda M, Oshiro N, Hara K, Edenhofer F, et al. mTOR is essential for growth and proliferation in early mouse embryos and embryonic stem cells. Mol Cell Biol 2004; 24:6710 - 8; http://dx.doi.org/10.1128/MCB.24.15.6710-6718.2004; PMID: 15254238
   PubMed Web of Science ®Google Scholar
• Sarbassov DD, Ali SM, Kim DH, Guertin DA, Latek RR, Erdjument-Bromage H, et al. Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. Curr Biol 2004; 14:1296 - 302; http://dx.doi.org/10.1016/j.cub.2004.06.054; PMID: 15268862
   PubMed Web of Science ®Google Scholar
• Jacinto E, Loewith R, Schmidt A, Lin S, Rüegg MA, Hall A, et al. Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive. Nat Cell Biol 2004; 6:1122 - 8; http://dx.doi.org/10.1038/ncb1183; PMID: 15467718
   PubMed Web of Science ®Google Scholar
• Kim DH, Sarbassov DD, Ali SM, King JE, Latek RR, Erdjument-Bromage H, et al. mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell 2002; 110:163 - 75; http://dx.doi.org/10.1016/S0092-8674(02)00808-5; PMID: 12150925
   PubMed Web of Science ®Google Scholar
• Vander Haar E, Lee SI, Bandhakavi S, Griffin TJ, Kim DH. Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40. Nat Cell Biol 2007; 9:316 - 23; http://dx.doi.org/10.1038/ncb1547; PMID: 17277771
   PubMed Web of Science ®Google Scholar
• Sarbassov DD, Guertin DA, Ali SM, Sabatini DM. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 2005; 307:1098 - 101; http://dx.doi.org/10.1126/science.1106148; PMID: 15718470
   PubMed Web of Science ®Google Scholar
• Benvenuto G, Li S, Brown SJ, Braverman R, Vass WC, Cheadle JP, et al. The tuberous sclerosis-1 (TSC1) gene product hamartin suppresses cell growth and augments the expression of the TSC2 product tuberin by inhibiting its ubiquitination. Oncogene 2000; 19:6306 - 16; http://dx.doi.org/10.1038/sj.onc.1204009; PMID: 11175345
   PubMed Web of Science ®Google Scholar
• Chong-Kopera H, Inoki K, Li Y, Zhu T, Garcia-Gonzalo FR, Rosa JL, et al. TSC1 stabilizes TSC2 by inhibiting the interaction between TSC2 and the HERC1 ubiquitin ligase. J Biol Chem 2006; 281:8313 - 6; http://dx.doi.org/10.1074/jbc.C500451200; PMID: 16464865
   PubMed Web of Science ®Google Scholar
• Manning BD, Tee AR, Logsdon MN, Blenis J, Cantley LC. Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway. Mol Cell 2002; 10:151 - 62; http://dx.doi.org/10.1016/S1097-2765(02)00568-3; PMID: 12150915
   PubMed Web of Science ®Google Scholar
• Inoki K, Li Y, Zhu T, Wu J, Guan KL. TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Nat Cell Biol 2002; 4:648 - 57; http://dx.doi.org/10.1038/ncb839; PMID: 12172553
   PubMed Web of Science ®Google Scholar
• Zhang H, Cicchetti G, Onda H, Koon HB, Asrican K, Bajraszewski N, et al. Loss of Tsc1/Tsc2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR. J Clin Invest 2003; 112:1223 - 33; PMID: 14561707
   PubMed Web of Science ®Google Scholar
• Garami A, Zwartkruis FJ, Nobukuni T, Joaquin M, Roccio M, Stocker H, et al. Insulin activation of Rheb, a mediator of mTOR/S6K/4E-BP signaling, is inhibited by TSC1 and 2. Mol Cell 2003; 11:1457 - 66; http://dx.doi.org/10.1016/S1097-2765(03)00220-X; PMID: 12820960
   PubMed Web of Science ®Google Scholar
• Inoki K, Zhu T, Guan KL. TSC2 mediates cellular energy response to control cell growth and survival. Cell 2003; 115:577 - 90; http://dx.doi.org/10.1016/S0092-8674(03)00929-2; PMID: 14651849
   PubMed Web of Science ®Google Scholar
• Dan HC, Sun M, Yang L, Feldman RI, Sui XM, Ou CC, et al. Phosphatidylinositol 3-kinase/Akt pathway regulates tuberous sclerosis tumor suppressor complex by phosphorylation of tuberin. J Biol Chem 2002; 277:35364 - 70; http://dx.doi.org/10.1074/jbc.M205838200; PMID: 12167664
   PubMed Web of Science ®Google Scholar
• Inoki K, Ouyang H, Zhu T, Lindvall C, Wang Y, Zhang X, et al. TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth. Cell 2006; 126:955 - 68; http://dx.doi.org/10.1016/j.cell.2006.06.055; PMID: 16959574
   PubMed Web of Science ®Google Scholar
• Kim E, Goraksha-Hicks P, Li L, Neufeld TP, Guan KL. Regulation of TORC1 by Rag GTPases in nutrient response. Nat Cell Biol 2008; 10:935 - 45; http://dx.doi.org/10.1038/ncb1753; PMID: 18604198
   PubMed Web of Science ®Google Scholar
• Sancak Y, Peterson TR, Shaul YD, Lindquist RA, Thoreen CC, Bar-Peled L, et al. The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1. Science 2008; 320:1496 - 501; http://dx.doi.org/10.1126/science.1157535; PMID: 18497260
   PubMed Web of Science ®Google Scholar
• Findlay GM, Yan L, Procter J, Mieulet V, Lamb RFA. A MAP4 kinase related to Ste20 is a nutrient-sensitive regulator of mTOR signalling. Biochem J 2007; 403:13 - 20; http://dx.doi.org/10.1042/BJ20061881; PMID: 17253963
   PubMed Web of Science ®Google Scholar
• Byfield MP, Murray JT, Backer JM. hVps34 is a nutrient-regulated lipid kinase required for activation of p70 S6 kinase. J Biol Chem 2005; 280:33076 - 82; http://dx.doi.org/10.1074/jbc.M507201200; PMID: 16049009
   PubMed Web of Science ®Google Scholar
• Nobukuni T, Joaquin M, Roccio M, Dann SG, Kim SY, Gulati P, et al. Amino acids mediate mTOR/raptor signaling through activation of class 3 phosphatidylinositol 3OH-kinase. Proc Natl Acad Sci USA 2005; 102:14238 - 43; http://dx.doi.org/10.1073/pnas.0506925102; PMID: 16176982
   PubMed Web of Science ®Google Scholar
• Reiling JH, Hafen E. The hypoxia-induced paralogs Scylla and Charybdis inhibit growth by down-regulating S6K activity upstream of TSC in Drosophila. Genes Dev 2004; 18:2879 - 92; http://dx.doi.org/10.1101/gad.322704; PMID: 15545626
   PubMed Web of Science ®Google Scholar
• Brugarolas J, Lei K, Hurley RL, Manning BD, Reiling JH, Hafen E, et al. Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex. Genes Dev 2004; 18:2893 - 904; http://dx.doi.org/10.1101/gad.1256804; PMID: 15545625
   PubMed Web of Science ®Google Scholar
• Gwinn DM, Shackelford DB, Egan DF, Mihaylova MM, Mery A, Vasquez DS, et al. AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol Cell 2008; 30:214 - 26; http://dx.doi.org/10.1016/j.molcel.2008.03.003; PMID: 18439900
   PubMed Web of Science ®Google Scholar
• Zheng M, Wang YH, Wu XN, Wu SQ, Lu BJ, Dong MQ, et al. Inactivation of Rheb by PRAK-mediated phosphorylation is essential for energy-depletion-induced suppression of mTORC1. Nat Cell Biol 2011; 13:263 - 72; http://dx.doi.org/10.1038/ncb2168; PMID: 21336308
   PubMed Web of Science ®Google Scholar
• Guertin DA, Sabatini DM. Defining the role of mTOR in cancer. Cancer Cell 2007; 12:9 - 22; http://dx.doi.org/10.1016/j.ccr.2007.05.008; PMID: 17613433
   PubMed Web of Science ®Google Scholar
• Hay N, Sonenberg N. Upstream and downstream of mTOR. Genes Dev 2004; 18:1926 - 45; http://dx.doi.org/10.1101/gad.1212704; PMID: 15314020
   PubMed Web of Science ®Google Scholar
• Harris TE, Lawrence JC Jr.. TOR signaling. Sci STKE 2003; 2003:re15; http://dx.doi.org/10.1126/stke.2122003re15; PMID: 14668532
   PubMedGoogle Scholar
• Fingar DC, Salama S, Tsou C, Harlow E, Blenis J. Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E. Genes Dev 2002; 16:1472 - 87; http://dx.doi.org/10.1101/gad.995802; PMID: 12080086
   PubMed Web of Science ®Google Scholar
• Weber JD, Gutmann DH. Deconvoluting mTOR biology. Cell Cycle 2012; 11:236 - 48; http://dx.doi.org/10.4161/cc.11.2.19022; PMID: 22214661
   PubMed Web of Science ®Google Scholar
• Magnuson B, Ekim B, Fingar DC. Regulation and function of ribosomal protein S6 kinase (S6K) within mTOR signalling networks. Biochem J 2012; 441:1 - 21; http://dx.doi.org/10.1042/BJ20110892; PMID: 22168436
   PubMed Web of Science ®Google Scholar
• Raught B, Peiretti F, Gingras AC, Livingstone M, Shahbazian D, Mayeur GL, et al. Phosphorylation of eucaryotic translation initiation factor 4B Ser422 is modulated by S6 kinases. EMBO J 2004; 23:1761 - 9; http://dx.doi.org/10.1038/sj.emboj.7600193; PMID: 15071500
   PubMed Web of Science ®Google Scholar
• Shahbazian D, Roux PP, Mieulet V, Cohen MS, Raught B, Taunton J, et al. The mTOR/PI3K and MAPK pathways converge on eIF4B to control its phosphorylation and activity. EMBO J 2006; 25:2781 - 91; http://dx.doi.org/10.1038/sj.emboj.7601166; PMID: 16763566
   PubMed Web of Science ®Google Scholar
• Wang X, Li W, Williams M, Terada N, Alessi DR, Proud CG. Regulation of elongation factor 2 kinase by p90(RSK1) and p70 S6 kinase. EMBO J 2001; 20:4370 - 9; http://dx.doi.org/10.1093/emboj/20.16.4370; PMID: 11500364
   PubMed Web of Science ®Google Scholar
• Richardson CJ, Bröenstrup M, Fingar DC, Jülich K, Ballif BA, Gygi S, et al. SKAR is a specific target of S6 kinase 1 in cell growth control. Curr Biol 2004; 14:1540 - 9; http://dx.doi.org/10.1016/j.cub.2004.08.061; PMID: 15341740
   PubMed Web of Science ®Google Scholar
• Wilson KF, Wu WJ, Cerione RA. Cdc42 stimulates RNA splicing via the S6 kinase and a novel S6 kinase target, the nuclear cap-binding complex. J Biol Chem 2000; 275:37307 - 10; http://dx.doi.org/10.1074/jbc.C000482200; PMID: 10973943
   PubMed Web of Science ®Google Scholar
• Tremblay F, Marette A. Amino acid and insulin signaling via the mTOR/p70 S6 kinase pathway. A negative feedback mechanism leading to insulin resistance in skeletal muscle cells. J Biol Chem 2001; 276:38052 - 60; PMID: 11498541
   PubMed Web of Science ®Google Scholar
• Manning BD. Balancing Akt with S6K: implications for both metabolic diseases and tumorigenesis. J Cell Biol 2004; 167:399 - 403; http://dx.doi.org/10.1083/jcb.200408161; PMID: 15533996
   PubMed Web of Science ®Google Scholar
• Lin TA, Kong X, Haystead TA, Pause A, Belsham G, Sonenberg N, et al. PHAS-I as a link between mitogen-activated protein kinase and translation initiation. Science 1994; 266:653 - 6; http://dx.doi.org/10.1126/science.7939721; PMID: 7939721
   PubMed Web of Science ®Google Scholar
• Pause A, Belsham GJ, Gingras AC, Donzé O, Lin TA, Lawrence JC Jr., et al. Insulin-dependent stimulation of protein synthesis by phosphorylation of a regulator of 5′-cap function. Nature 1994; 371:762 - 7; http://dx.doi.org/10.1038/371762a0; PMID: 7935836
   PubMed Web of Science ®Google Scholar
• Fingar DC, Richardson CJ, Tee AR, Cheatham L, Tsou C, Blenis J. mTOR controls cell cycle progression through its cell growth effectors S6K1 and 4E-BP1/eukaryotic translation initiation factor 4E. Mol Cell Biol 2004; 24:200 - 16; http://dx.doi.org/10.1128/MCB.24.1.200-216.2004; PMID: 14673156
   PubMed Web of Science ®Google Scholar
• Le Bacquer O, Petroulakis E, Paglialunga S, Poulin F, Richard D, Cianflone K, et al. Elevated sensitivity to diet-induced obesity and insulin resistance in mice lacking 4E-BP1 and 4E-BP2. J Clin Invest 2007; 117:387 - 96; http://dx.doi.org/10.1172/JCI29528; PMID: 17273556
   PubMed Web of Science ®Google Scholar
• Polak P, Cybulski N, Feige JN, Auwerx J, Rüegg MA, Hall MN. Adipose-specific knockout of raptor results in lean mice with enhanced mitochondrial respiration. Cell Metab 2008; 8:399 - 410; http://dx.doi.org/10.1016/j.cmet.2008.09.003; PMID: 19046571
   PubMed Web of Science ®Google Scholar
• Bentzinger CF, Romanino K, Cloëtta D, Lin S, Mascarenhas JB, Oliveri F, et al. Skeletal muscle-specific ablation of raptor, but not of rictor, causes metabolic changes and results in muscle dystrophy. Cell Metab 2008; 8:411 - 24; http://dx.doi.org/10.1016/j.cmet.2008.10.002; PMID: 19046572
   PubMed Web of Science ®Google Scholar
• Sengupta S, Peterson TR, Laplante M, Oh S, Sabatini DM. mTORC1 controls fasting-induced ketogenesis and its modulation by ageing. Nature 2010; 468:1100 - 4; http://dx.doi.org/10.1038/nature09584; PMID: 21179166
   PubMed Web of Science ®Google Scholar
• Gu Y, Lindner J, Kumar A, Yuan W, Magnuson MA. Rictor/mTORC2 is essential for maintaining a balance between beta-cell proliferation and cell size. Diabetes 2011; 60:827 - 37; http://dx.doi.org/10.2337/db10-1194; PMID: 21266327
   PubMed Web of Science ®Google Scholar
• Zhang N, Su D, Qu S, Tse T, Bottino R, Balamurugan AN, et al. Sirolimus is associated with reduced islet engraftment and impaired beta-cell function. Diabetes 2006; 55:2429 - 36; http://dx.doi.org/10.2337/db06-0173; PMID: 16936190
   PubMed Web of Science ®Google Scholar
• Bell E, Cao X, Moibi JA, Greene SR, Young R, Trucco M, et al. Rapamycin has a deleterious effect on MIN-6 cells and rat and human islets. Diabetes 2003; 52:2731 - 9; http://dx.doi.org/10.2337/diabetes.52.11.2731; PMID: 14578291
   PubMed Web of Science ®Google Scholar
• Shimodahira M, Fujimoto S, Mukai E, Nakamura Y, Nishi Y, Sasaki M, et al. Rapamycin impairs metabolism-secretion coupling in rat pancreatic islets by suppressing carbohydrate metabolism. J Endocrinol 2010; 204:37 - 46; http://dx.doi.org/10.1677/JOE-09-0216; PMID: 19812126
   PubMed Web of Science ®Google Scholar
• Johnson JD, Ao Z, Ao P, Li H, Dai LJ, He Z, et al. Different effects of FK506, rapamycin, and mycophenolate mofetil on glucose-stimulated insulin release and apoptosis in human islets. Cell Transplant 2009; 18:833 - 45; http://dx.doi.org/10.3727/096368909X471198; PMID: 19500470
   PubMed Web of Science ®Google Scholar
• Balcazar N, Sathyamurthy A, Elghazi L, Gould A, Weiss A, Shiojima I, et al. mTORC1 activation regulates beta-cell mass and proliferation by modulation of cyclin D2 synthesis and stability. J Biol Chem 2009; 284:7832 - 42; http://dx.doi.org/10.1074/jbc.M807458200; PMID: 19144649
   PubMed Web of Science ®Google Scholar
• Zahr E, Molano RD, Pileggi A, Ichii H, Jose SS, Bocca N, et al. Rapamycin impairs in vivo proliferation of islet beta-cells. Transplantation 2007; 84:1576 - 83; http://dx.doi.org/10.1097/01.tp.0000296035.48728.28; PMID: 18165767
   PubMed Web of Science ®Google Scholar
• Niclauss N, Bosco D, Morel P, Giovannoni L, Berney T, Parnaud G. Rapamycin impairs proliferation of transplanted islet β cells. Transplantation 2011; 91:714 - 22; PMID: 21297554
   PubMed Web of Science ®Google Scholar
• Teutonico A, Schena PF, Di Paolo S. Glucose metabolism in renal transplant recipients: effect of calcineurin inhibitor withdrawal and conversion to sirolimus. J Am Soc Nephrol 2005; 16:3128 - 35; http://dx.doi.org/10.1681/ASN.2005050487; PMID: 16107580
   PubMed Web of Science ®Google Scholar
• Di Paolo S, Teutonico A, Leogrande D, Capobianco C, Schena PF. Chronic inhibition of mammalian target of rapamycin signaling downregulates insulin receptor substrates 1 and 2 and AKT activation: A crossroad between cancer and diabetes?. J Am Soc Nephrol 2006; 17:2236 - 44; http://dx.doi.org/10.1681/ASN.2006030196; PMID: 16807405
   PubMed Web of Science ®Google Scholar
• Harrison DE, Strong R, Sharp ZD, Nelson JF, Astle CM, Flurkey K, et al. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature 2009; 460:392 - 5; PMID: 19587680
   PubMed Web of Science ®Google Scholar
• Veilleux A, Houde VP, Bellmann K, Marette A. Chronic inhibition of the mTORC1/S6K1 pathway increases insulin-induced PI3K activity but inhibits Akt2 and glucose transport stimulation in 3T3-L1 adipocytes. Mol Endocrinol 2010; 24:766 - 78; http://dx.doi.org/10.1210/me.2009-0328; PMID: 20203102
   PubMed Web of Science ®Google Scholar
• Choo AY, Blenis J. Not all substrates are treated equally: implications for mTOR, rapamycin-resistance and cancer therapy. Cell Cycle 2009; 8:567 - 72; http://dx.doi.org/10.4161/cc.8.4.7659; PMID: 19197153
   PubMed Web of Science ®Google Scholar
• Hamada S, Hara K, Hamada T, Yasuda H, Moriyama H, Nakayama R, et al. Upregulation of the mammalian target of rapamycin complex 1 pathway by Ras homolog enriched in brain in pancreatic beta-cells leads to increased beta-cell mass and prevention of hyperglycemia. Diabetes 2009; 58:1321 - 32; http://dx.doi.org/10.2337/db08-0519; PMID: 19258434
   PubMed Web of Science ®Google Scholar
• Gao X, Pan D. TSC1 and TSC2 tumor suppressors antagonize insulin signaling in cell growth. Genes Dev 2001; 15:1383 - 92; http://dx.doi.org/10.1101/gad.901101; PMID: 11390358
   PubMed Web of Science ®Google Scholar
• Potter CJ, Pedraza LG, Huang H, Xu T. The tuberous sclerosis complex (TSC) pathway and mechanism of size control. Biochem Soc Trans 2003; 31:584 - 6; http://dx.doi.org/10.1042/BST0310584; PMID: 12773160
   PubMed Web of Science ®Google Scholar
• Matsumoto S, Bandyopadhyay A, Kwiatkowski DJ, Maitra U, Matsumoto T. Role of the Tsc1-Tsc2 complex in signaling and transport across the cell membrane in the fission yeast Schizosaccharomyces pombe. Genetics 2002; 161:1053 - 63; PMID: 12136010
   PubMed Web of Science ®Google Scholar
• Mori H, Inoki K, Opland D, Münzberg H, Villanueva EC, Faouzi M, et al. Critical roles for the TSC-mTOR pathway in β-cell function. Am J Physiol Endocrinol Metab 2009; 297:E1013 - 22; http://dx.doi.org/10.1152/ajpendo.00262.2009; PMID: 19690069
   PubMedGoogle Scholar
• Mori H, Inoki K, Münzberg H, Opland D, Faouzi M, Villanueva EC, et al. Critical role for hypothalamic mTOR activity in energy balance. Cell Metab 2009; 9:362 - 74; http://dx.doi.org/10.1016/j.cmet.2009.03.005; PMID: 19356717
   PubMed Web of Science ®Google Scholar
• Wicksteed B, Brissova M, Yan W, Opland DM, Plank JL, Reinert RB, et al. Conditional gene targeting in mouse pancreatic ß-Cells: analysis of ectopic Cre transgene expression in the brain. Diabetes 2010; 59:3090 - 8; http://dx.doi.org/10.2337/db10-0624; PMID: 20802254
   PubMed Web of Science ®Google Scholar
• Dowling RJO, Topisirovic I, Alain T, Bidinosti M, Fonseca BD, Petroulakis E, et al. mTORC1-mediated cell proliferation, but not cell growth, controlled by the 4E-BPs. Science 2010; 328:1172 - 6; http://dx.doi.org/10.1126/science.1187532; PMID: 20508131
   PubMed Web of Science ®Google Scholar
• Elghazi L, Balcazar N, Blandino-Rosano M, Cras-Méneur C, Fatrai S, Gould AP, et al. Decreased IRS signaling impairs beta-cell cycle progression and survival in transgenic mice overexpressing S6K in beta-cells. Diabetes 2010; 59:2390 - 9; http://dx.doi.org/10.2337/db09-0851; PMID: 20622167
   PubMed Web of Science ®Google Scholar
• Beretta L, Gingras AC, Svitkin YV, Hall MN, Sonenberg N. Rapamycin blocks the phosphorylation of 4E-BP1 and inhibits cap-dependent initiation of translation. EMBO J 1996; 15:658 - 64; PMID: 8599949
   PubMed Web of Science ®Google Scholar
• Hara K, Yonezawa K, Weng QP, Kozlowski MT, Belham C, Avruch J. Amino acid sufficiency and mTOR regulate p70 S6 kinase and eIF-4E BP1 through a common effector mechanism. J Biol Chem 1998; 273:14484 - 94; http://dx.doi.org/10.1074/jbc.273.23.14484; PMID: 9603962
   PubMed Web of Science ®Google Scholar
• Yamaguchi S, Ishihara H, Yamada T, Tamura A, Usui M, Tominaga R, et al. ATF4-mediated induction of 4E-BP1 contributes to pancreatic beta cell survival under endoplasmic reticulum stress. Cell Metab 2008; 7:269 - 76; http://dx.doi.org/10.1016/j.cmet.2008.01.008; PMID: 18316032
   PubMed Web of Science ®Google Scholar
• Xu G, Kwon G, Marshall CA, Lin TA, Lawrence JC Jr., McDaniel ML. Branched-chain amino acids are essential in the regulation of PHAS-I and p70 S6 kinase by pancreatic beta-cells. A possible role in protein translation and mitogenic signaling. J Biol Chem 1998; 273:28178 - 84; http://dx.doi.org/10.1074/jbc.273.43.28178; PMID: 9774438
   PubMed Web of Science ®Google Scholar
• Xu G, Marshall CA, Lin TA, Kwon G, Munivenkatappa RB, Hill JR, et al. Insulin mediates glucose-stimulated phosphorylation of PHAS-I by pancreatic beta cells. An insulin-receptor mechanism for autoregulation of protein synthesis by translation. J Biol Chem 1998; 273:4485 - 91; http://dx.doi.org/10.1074/jbc.273.8.4485; PMID: 9468502
   PubMed Web of Science ®Google Scholar
• Xu G, Kwon G, Cruz WS, Marshall CA, McDaniel ML. Metabolic regulation by leucine of translation initiation through the mTOR-signaling pathway by pancreatic beta-cells. Diabetes 2001; 50:353 - 60; http://dx.doi.org/10.2337/diabetes.50.2.353; PMID: 11272147
   PubMed Web of Science ®Google Scholar
• Kwon G, Marshall CA, Pappan KL, Remedi MS, McDaniel ML. Signaling elements involved in the metabolic regulation of mTOR by nutrients, incretins, and growth factors in islets. Diabetes 2004; 53:Suppl 3 S225 - 32; http://dx.doi.org/10.2337/diabetes.53.suppl_3.S225; PMID: 15561916
   PubMedGoogle Scholar
• Bidinosti M, Ran I, Sanchez-Carbente MR, Martineau Y, Gingras A-C, Gkogkas C, et al. Postnatal deamidation of 4E-BP2 in brain enhances its association with raptor and alters kinetics of excitatory synaptic transmission. Mol Cell 2010; 37:797 - 808; http://dx.doi.org/10.1016/j.molcel.2010.02.022; PMID: 20347422
   PubMed Web of Science ®Google Scholar
• Kimball SR, Jefferson LS. Molecular mechanisms through which amino acids mediate signaling through the mammalian target of rapamycin. Curr Opin Clin Nutr Metab Care 2004; 7:39 - 44; http://dx.doi.org/10.1097/00075197-200401000-00008; PMID: 15090902
   PubMed Web of Science ®Google Scholar
• Um SH, D’Alessio D, Thomas G. Nutrient overload, insulin resistance, and ribosomal protein S6 kinase 1, S6K1. Cell Metab 2006; 3:393 - 402; http://dx.doi.org/10.1016/j.cmet.2006.05.003; PMID: 16753575
   PubMed Web of Science ®Google Scholar
• Pende M, Kozma SC, Jaquet M, Oorschot V, Burcelin R, Le Marchand-Brustel Y, et al. Hypoinsulinaemia, glucose intolerance and diminished beta-cell size in S6K1-deficient mice. Nature 2000; 408:994 - 7; http://dx.doi.org/10.1038/35050135; PMID: 11140689
   PubMed Web of Science ®Google Scholar
• Shima H, Pende M, Chen Y, Fumagalli S, Thomas G, Kozma SC. Disruption of the p70(s6k)/p85(s6k) gene reveals a small mouse phenotype and a new functional S6 kinase. EMBO J 1998; 17:6649 - 59; http://dx.doi.org/10.1093/emboj/17.22.6649; PMID: 9822608
   PubMed Web of Science ®Google Scholar
• Copps KD, Hancer NJ, Opare-Ado L, Qiu W, Walsh C, White MF. Irs1 serine 307 promotes insulin sensitivity in mice. Cell Metab 2010; 11:84 - 92; http://dx.doi.org/10.1016/j.cmet.2009.11.003; PMID: 20074531
   PubMed Web of Science ®Google Scholar
• Pende M, Um SH, Mieulet V, Sticker M, Goss VL, Mestan J, et al. S6K1(-/-)/S6K2(-/-) mice exhibit perinatal lethality and rapamycin-sensitive 5′-terminal oligopyrimidine mRNA translation and reveal a mitogen-activated protein kinase-dependent S6 kinase pathway. Mol Cell Biol 2004; 24:3112 - 24; http://dx.doi.org/10.1128/MCB.24.8.3112-3124.2004; PMID: 15060135
   PubMed Web of Science ®Google Scholar
• Alliouachene S, Tuttle RL, Boumard S, Lapointe T, Berissi S, Germain S, et al. Constitutively active Akt1 expression in mouse pancreas requires S6 kinase 1 for insulinoma formation. J Clin Invest 2008; 118:3629 - 38; http://dx.doi.org/10.1172/JCI35237; PMID: 18846252
   PubMed Web of Science ®Google Scholar
• Ruvinsky I, Sharon N, Lerer T, Cohen H, Stolovich-Rain M, Nir T, et al. Ribosomal protein S6 phosphorylation is a determinant of cell size and glucose homeostasis. Genes Dev 2005; 19:2199 - 211; http://dx.doi.org/10.1101/gad.351605; PMID: 16166381
   PubMed Web of Science ®Google Scholar
• Cota D, Matter EK, Woods SC, Seeley RJ. The role of hypothalamic mammalian target of rapamycin complex 1 signaling in diet-induced obesity. J Neurosci 2008; 28:7202 - 8; http://dx.doi.org/10.1523/JNEUROSCI.1389-08.2008; PMID: 18614690
   PubMed Web of Science ®Google Scholar
• Dor Y, Brown J, Martinez OI, Melton DA. Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation. Nature 2004; 429:41 - 6; http://dx.doi.org/10.1038/nature02520; PMID: 15129273
   PubMed Web of Science ®Google Scholar
• Withers DJ, Gutierrez JS, Towery H, Burks DJ, Ren J-M, Previs S, et al. Disruption of IRS-2 causes type 2 diabetes in mice. Nature 1998; 391:900 - 4; http://dx.doi.org/10.1038/36116; PMID: 9495343
   PubMed Web of Science ®Google Scholar
• Withers DJ, Burks DJ, Towery HH, Altamuro SL, Flint CL, White MF. Irs-2 coordinates Igf-1 receptor-mediated beta-cell development and peripheral insulin signalling. Nat Genet 1999; 23:32 - 40; http://dx.doi.org/10.1038/12631; PMID: 10471495
   PubMed Web of Science ®Google Scholar
• Hennige AM, Burks DJ, Ozcan U, Kulkarni RN, Ye J, Park S, et al. Upregulation of insulin receptor substrate-2 in pancreatic beta cells prevents diabetes. J Clin Invest 2003; 112:1521 - 32; PMID: 14617753
   PubMed Web of Science ®Google Scholar
• Lingohr MK, Dickson LM, McCuaig JF, Hugl SR, Twardzik DR, Rhodes CJ. Activation of IRS-2-mediated signal transduction by IGF-1, but not TGF-alpha or EGF, augments pancreatic beta-cell proliferation. Diabetes 2002; 51:966 - 76; http://dx.doi.org/10.2337/diabetes.51.4.966; PMID: 11916914
   PubMed Web of Science ®Google Scholar
• Lingohr MK, Dickson LM, Wrede CE, Briaud I, McCuaig JF, Myers MG Jr., et al. Decreasing IRS-2 expression in pancreatic beta-cells (INS-1) promotes apoptosis, which can be compensated for by introduction of IRS-4 expression. Mol Cell Endocrinol 2003; 209:17 - 31; http://dx.doi.org/10.1016/j.mce.2003.08.003; PMID: 14604813
   PubMed Web of Science ®Google Scholar
• Tokunaga C, Yoshino K, Yonezawa K. mTOR integrates amino acid- and energy-sensing pathways. Biochem Biophys Res Commun 2004; 313:443 - 6; http://dx.doi.org/10.1016/j.bbrc.2003.07.019; PMID: 14684182
   PubMed Web of Science ®Google Scholar
• Meijer AJ, Dubbelhuis PF. Amino acid signalling and the integration of metabolism. Biochem Biophys Res Commun 2004; 313:397 - 403; http://dx.doi.org/10.1016/j.bbrc.2003.07.012; PMID: 14684175
   PubMed Web of Science ®Google Scholar
• Miloloza A, Kubista M, Rosner M, Hengstschläger M. Evidence for separable functions of tuberous sclerosis gene products in mammalian cell cycle regulation. J Neuropathol Exp Neurol 2002; 61:154 - 63; PMID: 11853018
   PubMed Web of Science ®Google Scholar
• Soucek T, Rosner M, Miloloza A, Kubista M, Cheadle JP, Sampson JR, et al. Tuberous sclerosis causing mutants of the TSC2 gene product affect proliferation and p27 expression. Oncogene 2001; 20:4904 - 9; http://dx.doi.org/10.1038/sj.onc.1204627; PMID: 11521203
   PubMed Web of Science ®Google Scholar
• Hengstschläger M, Rodman DM, Miloloza A, Hengstschläger-Ottnad E, Rosner M, Kubista M. Tuberous sclerosis gene products in proliferation control. Mutat Res 2001; 488:233 - 9; http://dx.doi.org/10.1016/S1383-5742(01)00058-8; PMID: 11397651
   PubMed Web of Science ®Google Scholar
• Wullschleger S, Loewith R, Hall MN. TOR signaling in growth and metabolism. Cell 2006; 124:471 - 84; http://dx.doi.org/10.1016/j.cell.2006.01.016; PMID: 16469695
   PubMed Web of Science ®Google Scholar
• Manning BD, Logsdon MN, Lipovsky AI, Abbott D, Kwiatkowski DJ, Cantley LC. Feedback inhibition of Akt signaling limits the growth of tumors lacking Tsc2. Genes Dev 2005; 19:1773 - 8; http://dx.doi.org/10.1101/gad.1314605; PMID: 16027169
   PubMed Web of Science ®Google Scholar
• Paik J-H, Kollipara R, Chu G, Ji H, Xiao Y, Ding Z, et al. FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis. Cell 2007; 128:309 - 23; http://dx.doi.org/10.1016/j.cell.2006.12.029; PMID: 17254969
   PubMed Web of Science ®Google Scholar
• Tremblay F, Marette A. Amino acid and insulin signaling via the mTOR/p70 S6 kinase pathway. A negative feedback mechanism leading to insulin resistance in skeletal muscle cells. J Biol Chem 2001; 276:38052 - 60; PMID: 11498541
   PubMed Web of Science ®Google Scholar
• Krebs M, Brunmair B, Brehm A, Artwohl M, Szendroedi J, Nowotny P, et al. The Mammalian target of rapamycin pathway regulates nutrient-sensitive glucose uptake in man. Diabetes 2007; 56:1600 - 7; http://dx.doi.org/10.2337/db06-1016; PMID: 17329620
   PubMed Web of Science ®Google Scholar
• Ueno M, Carvalheira JBC, Tambascia RC, Bezerra RMN, Amaral ME, Carneiro EM, et al. Regulation of insulin signalling by hyperinsulinaemia: role of IRS-1/2 serine phosphorylation and the mTOR/p70 S6K pathway. Diabetologia 2005; 48:506 - 18; http://dx.doi.org/10.1007/s00125-004-1662-6; PMID: 15692808
   PubMed Web of Science ®Google Scholar
• Abe Y, Yoon SO, Kubota K, Mendoza MC, Gygi SP, Blenis J. p90 ribosomal S6 kinase and p70 ribosomal S6 kinase link phosphorylation of the eukaryotic chaperonin containing TCP-1 to growth factor, insulin, and nutrient signaling. J Biol Chem 2009; 284:14939 - 48; http://dx.doi.org/10.1074/jbc.M900097200; PMID: 19332537
   PubMed Web of Science ®Google Scholar